Anja Moncsek
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Development and Validation of a Scaffold-Free Human Multilineage Spheroid Model for Early Stage Cholangiopathies Driven by Cholangiocyte Senescence.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 24, 2024
The co-inhibitory receptor TIGIT promotes tissue-protective functions in T cells.
Journal: Nature immunology
Published: November 19, 2024
A single nucleotide polymorphism in the gene for GPR183 increases its surface expression on blood lymphocytes of patients with inflammatory bowel disease.
Journal: British journal of pharmacology
Published: May 25, 2020
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Journal: Nature reviews. Gastroenterology & hepatology
Published: April 29, 2020
NASH limits anti-tumour surveillance in immunotherapy-treated HCC.
Journal: Nature
Published: February 17, 2020
Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis.
Journal: Journal of lipid research
Published: February 26, 2019
The tumour microenvironment and immune milieu of cholangiocarcinoma.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 11, 2019
BCL-2 levels do not predict azathioprine treatment response in inflammatory bowel disease, but inhibition induces lymphocyte apoptosis and ameliorates colitis in mice.
Journal: Clinical and experimental immunology
Published: April 13, 2018
Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland.
Journal: Swiss medical weekly
Published: January 30, 2018
The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis.
Journal: Mucosal immunology
Published: January 25, 2018
Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice.
Journal: Hepatology (Baltimore, Md.)
Published: April 07, 2017
Last Updated: 09/26/2026